Pathogenic conditions associated with aberrant expression of ODF2L, MAST2 and KIF23 include ciliopathy, liver cancer and chronic myeloid leukemia, respectively (95–97). This evidence concerns the gene ODF2L and chronic myelogenous leukemia, BCR-ABL1 positive.